NATCOPHARMNSENATCO PHARMA LTD.· PharmaceuticalsHighNegative
Announced Tue, 14 Jul · 09:56 IST

Natco Pharma faces GST tax demand of about 60 lakhs from Andhra Pradesh authorities

Regulatory & Legal View source PDF

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.0%1-day move
₹979.55
prior close
₹974.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.2-0.4-0.4-1.0-1.5-3.6-2.8-1.9-5.8
Up moveDown movePending
AI summary

Natco Pharma received a GST order from the Andhra Pradesh tax authority covering the audit period from April 2020 to December 2024. The order relates to lower reporting under the Reverse Charge Mechanism in GSTR 3B returns. The total demand is about Rs 59.87 lakhs, split as Rs 21.35 lakhs tax, Rs 17.18 lakhs interest, and Rs 21.35 lakhs penalty. The company is evaluating the matter and will decide on the next course of action. Natco has stated there is no material impact on its financial or operational activities.

Likely market impact

Small tax demand of about 60 lakhs versus a large company size; not material per company. May appeal; watch for updates.